Combination therapy for chronic Pseudomonas aeruginosa respiratory infection associated with biofilm formation

被引:34
作者
Yanagihara, K [1 ]
Tomono, K [1 ]
Sawai, T [1 ]
Kuroki, M [1 ]
Kaneko, Y [1 ]
Ohno, H [1 ]
Higashiyama, Y [1 ]
Miyazaki, Y [1 ]
Hirakata, Y [1 ]
Maesaki, S [1 ]
Kadota, J [1 ]
Tashiro, T [1 ]
Kohno, S [1 ]
机构
[1] Nagasaki Univ, Sch Med, Dept Internal Med 2, Nagasaki 8528501, Japan
关键词
D O I
10.1093/jac/46.1.69
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
There had been no reports of investigations into biofilms in chronic respiratory infection in vivo. Recently, we established a new murine model of chronic respiratory infection with Pseudomonas aeruginosa. In the present study, we examined the bacteriological effect of combined clarithromycin and levofloxacin against chronic respiratory infection with P. aeruginosa. Scanning electron micrograph of the surface of the catheter intubated in mouse bronchus for 7 days demonstrated in vivo formation of a biofilm containing blood cells, complex fibrous structures and bacteria. Treatment with either clarithromycin alone or levofloxacin alone had no statistical effect on the number of viable bacteria in lung. The combined use of both drugs resulted in a significant decrease in the number of viable bacteria. The present experiment demonstrates that the newly established murine model was useful to investigate the treatment of biofilm-associated chronic respiratory infection with P. aeruginosa, and combination therapy with clarithromycin and levofloxacin was effective in biofilm-associated chronic respiratory infection.
引用
收藏
页码:69 / 72
页数:4
相关论文
共 15 条
  • [1] ENHANCED ACTIVITY OF COMBINATION OF TOBRAMYCIN AND PIPERACILLIN FOR ERADICATION OF SESSILE BIOFILM CELLS OF PSEUDOMONAS-AERUGINOSA
    ANWAR, H
    COSTERTON, JW
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (09) : 1666 - 1671
  • [2] CHUARD C, 1991, J INFECT DIS, V163, P1369
  • [3] ENZYMATIC MODIFICATION OF GLYCOCALYX IN THE TREATMENT OF EXPERIMENTAL ENDOCARDITIS DUE TO VIRIDANS STREPTOCOCCI
    DALL, L
    BARNES, WG
    LANE, JW
    MILLS, J
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1987, 156 (05) : 736 - 740
  • [4] GRAY ED, 1984, LANCET, V1, P365
  • [5] POTENTIAL EFFECTS OF ERYTHROMYCIN ON HOST DEFENSE SYSTEMS AND VIRULENCE OF PSEUDOMONAS-AERUGINOSA
    HIRAKATA, Y
    KAKU, M
    MIZUKANE, R
    ISHIDA, K
    FURUYA, N
    MATSUMOTO, T
    TATEDA, K
    YAMAGUCHI, K
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (09) : 1922 - 1927
  • [6] A MECHANISM OF ERYTHROMYCIN TREATMENT IN PATIENTS WITH DIFFUSE PANBRONCHIOLITIS
    KADOTA, J
    SAKITO, O
    KOHNO, S
    SAWA, H
    MUKAE, H
    ODA, H
    KAWAKAMI, K
    FUKUSHIMA, K
    HIRATANI, K
    HARA, K
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (01): : 153 - 159
  • [7] KOBAYASHI H, 1995, J INFECT CHEMOTHER, V1, P1, DOI DOI 10.1007/BF02347725
  • [8] PATHOGENESIS OF CYSTIC-FIBROSIS
    KOCH, C
    HOIBY, N
    [J]. LANCET, 1993, 341 (8852) : 1065 - 1069
  • [9] Kudoh S., 1987, JPN J THORAC DIS, V25, P632
  • [10] MODE OF GROWTH OF BACTERIAL PATHOGENS IN CHRONIC POLYMICROBIAL HUMAN OSTEOMYELITIS
    MARRIE, TJ
    COSTERTON, JW
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1985, 22 (06) : 924 - 933